The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Morozova M.A.

Mental Health Research Center

Beniashvili A.G.

Mental Health Research Center

Kostyuk G.P.

Alexeev Psychiatric Hospital no. 1 of the Department of Health of Moscow

Cheremin R.A.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

Burminsky D.S.

Mental Health Research Center

Lepilkina T.A.

Mental Health Research Center

Potanin S.S.

Mental Health Research Center

Rupchev G.E.

Mental Health Research Center

Alekseev A.A.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

Kulyutkin V.A.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

Ulyanov I.V.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

Zotova L.I.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

The technology of induction of physiological ketosis in asthenia of various origins and decreased resistance to cognitive and physical activity

Authors:

Morozova M.A., Beniashvili A.G., Kostyuk G.P., Cheremin R.A., Burminsky D.S., Lepilkina T.A., Potanin S.S., Rupchev G.E., Alekseev A.A., Kulyutkin V.A., Ulyanov I.V., Zotova L.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(10): 48‑54

DOI: 10.17116/jnevro202412410148

Read: 1350 times

Download PDF (RU)
Contact the author
Table of contents

THE TECHNOLOGY OF INDUCTION OF PHYSIOLOGICAL KETOSIS IN ASTHENIA OF VARIOUS ORIGINS AND DECREASED RESISTANCE TO COGNITIVE AND PHYSICAL ACTIVITY
THE TECHNOLOGY OF INDUCTION OF PHYSIOLOGICAL KETOSIS IN ASTHENIA OF VARIOUS ORIGINS AND DECREASED RESISTANCE TO COGNITIVE AND PHYSICAL ACTIVITY

To cite this article:

Morozova MA, Beniashvili AG, Kostyuk GP, et al. . The technology of induction of physiological ketosis in asthenia of various origins and decreased resistance to cognitive and physical activity. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(10):48‑54. (In Russ.)
https://doi.org/10.17116/jnevro202412410148

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Chro­nic fati­gue syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):28-33
Factors affe­cting the quality of life of patients with neurological mani­festations of post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):44-50
Arte­rial hype­rtension is an oxidative stress, as a pathogenetic target for the treatment of chro­nic cere­brovascular insu­fficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):84-90
Cognitive vascular diso­rders and morphometric para­meters of the prefrontal, dorsolateral cortex and thalamus in post-stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):91-95
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Cognitive impairment in asthenic diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):27-32
The study of the beha­vioral reactions and dura­tion of ultrasonic voca­lization in rats from fema­les stre­ssed during pregnancy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):117-123
Effe­cts of sema­glutide on mental health. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):28-36
Possibilities of using meldonium as part of complex therapy in patients with ischemic heart disease and chro­nic heart failure combined with obesity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):53-60
Abstract:

OBJECTIVE

To assess the possibility of achieving physiological ketosis with oral administration of beta-hydroxybutyrate salts and, if ketosis is achieved, to assess its effect on cognitive functioning in patients with brain dysfunction during the recovery period after a somatic disease.

MATERIAL AND METHODS

The study included 86 patients with complaints of asthenic manifestations (ICD-10 diagnoses F06; F07; R53). Half of the patients were included in the study group taking beta-hydroxybutyrate salts, and the other half were included in the control group taking placebo. The duration of administration was 15 days. The content of ketones in the blood was assessed immediately before and after taking the drug on the first and last days of the study. Subjective severity of asthenia manifestations was assessed using a visual-analog scale (VAS). The Montreal Cognitive Assessment and the Trial Making Test (TMT) were used to assess cognitive functions.

RESULTS

The control and study groups did not differ significantly in subjective and objective indicators of mental performance before taking the drug. At the end of the study, the blood ketone content in the experimental group was statistically significantly higher than in the control group. Physiological ketosis was achieved in 29 patients of the experimental group (67%). By the end of the study, the experimental group showed a significant improvement in all cognitive tests. At the same time, by the end of the study, only an improvement in TMT-A performance was noted in the control group. Also, in the experimental group, statistically significantly more patients achieved a significant improvement in mental performance on VAS tasks.

CONCLUSION

The results confirm the hypothesis that oral administration of beta-hydroxybutyrate can stimulate physiological ketosis. A significant positive dynamics of cognitive functioning of patients and a decrease in the severity of asthenia during beta-hydroxybutyrate intake are noted.

Keywords:

asthenia
ketosis
beta-hydroxybutyrate
cognitive functions

Authors:

Morozova M.A.

Mental Health Research Center

Beniashvili A.G.

Mental Health Research Center

Kostyuk G.P.

Alexeev Psychiatric Hospital no. 1 of the Department of Health of Moscow

Cheremin R.A.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

Burminsky D.S.

Mental Health Research Center

Lepilkina T.A.

Mental Health Research Center

Potanin S.S.

Mental Health Research Center

Rupchev G.E.

Mental Health Research Center

Alekseev A.A.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

Kulyutkin V.A.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

Ulyanov I.V.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

Zotova L.I.

Speech Pathology and Neurorehabilitation Center of the Department of Health of Moscow

Received:

13.06.2024

Accepted:

24.06.2024

Close metadata

References:

  1. Lincoln BC, Des Rosiers C, Brunengraber H. Metabolism of S-3-hydroxybutyrate in the perfused rat liver. Arch Biochem Biophys. 1987;259(1):149-156.  https://doi.org/10.1016/0003-9861(87)90480-2
  2. Puchalska P, Crawford PA. Metabolic and Signaling Roles of Ketone Bodies in Health and Disease. Annu Rev Nutr. 2021;41(1):49-77.  https://doi.org/10.1146/annurev-nutr-111120-111518
  3. Guelpa G. La lutte contre l’epiepsie par la desintoxication et par la reeducation alimentaire. Rev Ther Med Chir. 1911;78:8. 
  4. Poff AM, Moss S, Soliven M, et al. Ketone Supplementation: Meeting the Needs of the Brain in an Energy Crisis. Front Nutr. 2021;8:783659. https://doi.org/10.3389/fnut.2021.783659
  5. Wang L, Chen P, Xiao W. β-hydroxybutyrate as an Anti-Aging Metabolite. Nutrients. 2021;13(10):3420. https://doi.org/10.3390/nu13103420
  6. Courchesne-Loyer A, Croteau E, Castellano CA, et al. Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study. J Cereb Blood Flow Metab. 2017;37(7):2485-2493. https://doi.org/10.1177/0271678X16669366
  7. Jensen NJ, Wodschow HZ, Nilsson M, et al. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases. Int J Mol Sci. 2020;21(22):8767. https://doi.org/10.3390/ijms21228767
  8. Kovács Z, Brunner B, Ari C. Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases. Nutrients. 2021;13(7):2197. https://doi.org/10.3390/nu13072197
  9. Croteau E, Castellano CA, Fortier M, et al. Cunnane A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer’s disease. 2018;107:18-26.  https://doi.org/10.1016/j.exger.2017.07.004
  10. Ota M, Matsuo J, Ishida I, et al. Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement. Psychopharmacology (Berl). 2016;233(21-22):3797-3802. https://doi.org/10.1007/s00213-016-4414-7
  11. Abe S, Ezaki O, Suzuki M. Medium-Chain Triglycerides (8:0 and 10:0) Increase Mini-Mental State Examination (MMSE) Score in Frail Elderly Adults in a Randomized Controlled Trial. J Nutr. 2020;150(9):2383-2390. https://doi.org/10.1093/jn/nxaa186
  12. Jensen NJ, Nilsson M, Ingerslev JS, et al. Effects of β-hydroxybutyrate on cognition in patients with type 2 diabetes. Eur J Endocrinol. 2020;182(2):233-242.  https://doi.org/10.1530/EJE-19-0710
  13. Henderson ST, Vogel JL, Barr LJ, et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009;6:31.  https://doi.org/10.1186/1743-7075-6-31
  14. Ohnuma T, Toda A, Kimoto A, et al. Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study. Clin Interv Aging. 2016;11:29-36.  https://doi.org/10.2147/CIA.S95362
  15. Ota M, Matsuo J, Ishida I, et al. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease. Neurosci Lett. 2019;690:232-236.  https://doi.org/10.1016/j.neulet.2018.10.048
  16. Roy M, Fortier M, Rheault F, et al. A ketogenic supplement improves white matter energy supply and processing speed in mild cognitive impairment. Alzheimers Dement (N Y). 2021;7(1):e12217. https://doi.org/10.1002/trc2.12217
  17. Schweickart A, Batra R, Neth BJ, et al. A Modified Mediterranean Ketogenic Diet mitigates modifiable risk factors of Alzheimer’s Disease: a serum and CSF-based metabolic analysis. Published online November 27, 2023. https://doi.org/10.1101/2023.11.27.23298990
  18. Lilamand M, Porte B, Cognat E, et al. Are ketogenic diets promising for Alzheimer’s disease? A translational review. Alz Res Therapy. 2020;12(1):42.  https://doi.org/10.1186/s13195-020-00615-4
  19. Kovács Z, D’Agostino DP, Diamond D, et al. Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature. Front Psychiatry. 2019;10:363.  https://doi.org/10.3389/fpsyt.2019.00363
  20. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.  https://doi.org/10.1111/j.1532-5415.2005.53221.x
  21. Dalrymple-Alford JC, MacAskill MR, Nakas CT, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010;75(19):1717-1725. https://doi.org/10.1212/WNL.0b013e3181fc29c9
  22. Cummings J, Schwartz GG, Nicholls SJ, et al. Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial. J Alzheimers Dis. 2021;83(4):1703-1715. https://doi.org/10.3233/JAD-210570
  23. Lezak MD. Neuropsychological Assessment. New York: Oxford University Press; 1976. Accessed April 5, 2024. https://archive.org/details/neuropsychologic0000leza_s0a3
  24. Walsh JJ, Caldwell HG, Neudorf H, et al. Short-term ketone monoester supplementation improves cerebral blood flow and cognition in obesity: A randomized cross-over trial. J Physiol. 2021;599(21):4763-4778. https://doi.org/10.1113/JP281988
  25. Margolis LM, O’Fallon KS. Utility of Ketone Supplementation to Enhance Physical Performance: A Systematic Review. Adv Nutr. 2020;11(2):412-419.  https://doi.org/10.1093/advances/nmz104
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.